DBT anticorps (N-Term)
Aperçu rapide pour DBT anticorps (N-Term) (ABIN631072)
Antigène
Voir toutes DBT AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Specificité
- DBT antibody was raised against the N terminal of DBT
-
Purification
- Affinity purified
-
Immunogène
- DBT antibody was raised using the N terminal of DBT corresponding to a region with amino acids NYVCFFGYPSFKYSHPHHFLKTTAALRGQVVQFKLSDIGEGIREVTVKEW
-
-
-
-
Indications d'application
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
DBT Blocking Peptide, (ABIN5613129), is also available for use as a blocking control in assays to test for specificity of this DBT antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of DBT antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- DBT (Dihydrolipoamide Branched Chain Transacylase E2 (DBT))
-
Autre désignation
- DBT
-
Sujet
- The branched-chain alpha-keto dehydrogenase complex catalyzes the overall conversion of alpha-keto acids to acyl-CoA and CO2. It contains multiple copies of three enzymatic components: branched-chain alpha-keto acid decarboxylase (E1), lipoamide acyltransferase (E2) and lipoamide dehydrogenase (E3).
-
Poids moléculaire
- 46 kDa (MW of target protein)
Antigène
-